Javascript must be enabled to continue!
Expression level of the reprogramming factor NeuroD1 is critical for neuronal conversion efficiency from different cell types
View through CrossRef
SummarySeveral transcription factors, including NeuroD1, have been shown to act as neuronal reprogramming factors (RFs) that induce neuronal conversion from somatic cells. However, it remains unexplored whether expression levels of RFs in the original cells affect reprogramming efficiency. Here, we show that the neuronal reprogramming efficiency from two distinct glial cell types, microglia and astrocytes, is substantially dependent on the expression level of NeuroD1: low expression failed to induce neuronal reprogramming, whereas elevated NeuroD1 expression dramatically improved reprogramming efficiency in both cell types. Moreover, even under conditions where NeuroD1 expression was too low to induce effective conversion by itself, combined expression of three RFs (Ascl1, Brn2, and NeuroD1) facilitated the breaking down of cellular barriers, inducing neuronal reprogramming. Thus, our results suggest that a sufficiently high expression level of RFs or alternatively their combinatorial expression, is the key to achieving efficient neuronal reprogramming from different cells.Highlights▪High expression of NeuroD1 is required for neuronal conversion.▪Multiple infections with NeuroD1-expressing virus enhance neuronal reprogramming▪Combinatorial expression of NeuroD1 with other RFs facilitates neuronal conversioneTOC blurbIn this article, Matsuda-Ito et al. demonstrate that the efficacy of conversion into neurons from two distinct glial cells, microglia and astrocytes, depends on the NeuroD1 expression level. They also show that increased NeuroD1 expression alone enables efficient neuronal reprogramming in non-reactive astrocytes that were previously shown to be difficult to convert into neurons.
Title: Expression level of the reprogramming factor NeuroD1 is critical for neuronal conversion efficiency from different cell types
Description:
SummarySeveral transcription factors, including NeuroD1, have been shown to act as neuronal reprogramming factors (RFs) that induce neuronal conversion from somatic cells.
However, it remains unexplored whether expression levels of RFs in the original cells affect reprogramming efficiency.
Here, we show that the neuronal reprogramming efficiency from two distinct glial cell types, microglia and astrocytes, is substantially dependent on the expression level of NeuroD1: low expression failed to induce neuronal reprogramming, whereas elevated NeuroD1 expression dramatically improved reprogramming efficiency in both cell types.
Moreover, even under conditions where NeuroD1 expression was too low to induce effective conversion by itself, combined expression of three RFs (Ascl1, Brn2, and NeuroD1) facilitated the breaking down of cellular barriers, inducing neuronal reprogramming.
Thus, our results suggest that a sufficiently high expression level of RFs or alternatively their combinatorial expression, is the key to achieving efficient neuronal reprogramming from different cells.
Highlights▪High expression of NeuroD1 is required for neuronal conversion.
▪Multiple infections with NeuroD1-expressing virus enhance neuronal reprogramming▪Combinatorial expression of NeuroD1 with other RFs facilitates neuronal conversioneTOC blurbIn this article, Matsuda-Ito et al.
demonstrate that the efficacy of conversion into neurons from two distinct glial cells, microglia and astrocytes, depends on the NeuroD1 expression level.
They also show that increased NeuroD1 expression alone enables efficient neuronal reprogramming in non-reactive astrocytes that were previously shown to be difficult to convert into neurons.
Related Results
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Cell reprogramming modelled as transitions in a hierarchy of cell cycles
Cell reprogramming modelled as transitions in a hierarchy of cell cycles
We construct a model of cell reprogramming (the conversion of fully differentiated cells to a state of pluripotency, known as induced pluripotent stem cells, or iPSCs) which builds...
Chromatin states contribute to coordinated allelic transcriptional bursting to drive iPSC reprogramming
Chromatin states contribute to coordinated allelic transcriptional bursting to drive iPSC reprogramming
AbstractMolecular mechanisms behind the reprogramming of somatic cells to induced pluripotent stem cells (iPSC) remain poorly understood. While dynamic changes in gene expression a...
S-Phase Synchronization Facilitates the Early Progression of Induced-Cardiomyocyte Reprogramming through Enhanced Cell-Cycle Exit
S-Phase Synchronization Facilitates the Early Progression of Induced-Cardiomyocyte Reprogramming through Enhanced Cell-Cycle Exit
Direct reprogramming of fibroblasts into induced cardiomyocytes (iCMs) holds a great promise for regenerative medicine and has been studied in several major directions. However, ce...
Neuronal Activity Alters Neuron to OPC Synapses
Neuronal Activity Alters Neuron to OPC Synapses
AbstractThe mechanisms that drive the timing and specificity of oligodendrocyte myelination during development, or remyelination after injury or immune attack are not well understo...
Partial reprogramming as a therapeutic approach for heart disease: A state‐of‐the‐art review
Partial reprogramming as a therapeutic approach for heart disease: A state‐of‐the‐art review
AbstractHeart disease such as myocardial infarction is the first cause of mortality in all countries. Today, cardiac cell‐based therapy using de novo produced cardiac cells is cons...
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
AbstractNeurodegenerative disorders, including chemotherapy-induced cognitive impairment, are associated with neuronal mitochondrial dysfunction. Cisplatin, a commonly used chemoth...
Murine melanoma cells incomplete reprogramming using non‐viral vector
Murine melanoma cells incomplete reprogramming using non‐viral vector
AbstractObjectivesThe reprogramming of cancer cells into induced pluripotent stem cells or less aggressive cancer cells can provide a modern platform to study cancer‐related genes ...

